Evaluation of the effectiveness of pectin with trepang extract in the complex therapy of NSAID-associated lesions of the upper gastrointestinal tract
https://doi.org/10.21886/2712-8156-2026-7-1-62-68
Abstract
Objective: to evaluate the clinical efficacy of a biologically active pectin supplement with trepang extract in patients with NSAID-associated upper gastrointestinal lesions.
Material and methods: a prospective observational study included patients aged 18–75 years with NSAID-associated upper gastrointestinal lesions. We compared two groups of patients: the first group (n=25) received a combination of standard medications and a pectin complex with trepang extract, while the second group (n=25) received standard therapy in accordance with clinical guidelines.
Results: the group of patients receiving the combination therapy showed statistically significant improvements in treatment outcomes.
Conclusion: the use of a pectin complex with trepang extract as an adjunct to standard therapy enhances the effectiveness of treating NSAID-related gastropathies.
About the Authors
M. V. MokshinaRussian Federation
Margarita V. Mokshina, Cand. Sci. (Med.), Associate Professor at the Institute of Therapy and Instrumental Diagnostics
Vladivostok
V. A. Nevzorova
Russian Federation
Vera A. Nevzorova, Dr. Sci. (Med.), Professor, Director of the Institute of Therapy and Instrumental Diagnostics
Vladivostok
N. M. Kondrashova
Russian Federation
Nadezhda M. Kondrashova, Cand. Sci. (Med.), Associate Professor at the Institute of Therapy and Instrumental Diagnostics
Vladivostok
A. S. Moskalenko
Russian Federation
Aleksandra S. Moskalenko, рostgraduate student of the Department of General and Clinical Pharmacology; Gastroenterologist at the Gastroenterology Department
Vladivostok
E. V. Eliseeva
Russian Federation
Ekaterina V. Eliseeva, Dr. Sci. (Med.), Professor, Head of the Department of General and Clinical Pharmacology
Vladivostok
L. G. Priseko
Russian Federation
Lyudmila G. Priseko, Senior Lecturer at the Institute of Therapy and Instrumental Diagnostics
Vladivostok
References
1. Balukova E.V. NSAID-Induced Gastropathy: From Understanding the Mechanisms of Development to Developing a Prevention and Treatment Strategy. Russian Medical Journal. 2017;25(10):697-702. (In Russ.) eLIBRARY ID: 30282541 EDN: ZMRMPD
2. Karateev A.E. Nonsteroidal anti-inflammatory drugs in therapeutical practice. Therapy. 2024;10(1):138-148. (In Russ.) DOI: 10.18565/therapy.2024.1.138-148
3. Tryapyshko A.A., Dekhnich N.N. NSAID-Gastropathy: Patient Management Guide. A Review. Comorbidity Neurology. 2025;2(1):26-32. (In Russ.). DOI: 10.62505/3034-185x-2025-2-1-26-32
4. Lanas A. A review of the gastrointestinal safety data--a gastroenterologist's perspective. Rheumatology (Oxford). 2010;49 Suppl 2(Suppl 2):ii3-10. DOI: 10.1093/rheumatology/keq058
5. Dydykina I.S., Kovalenko P.S. Main aspects of prevention and treatment of NSAIDS-gastropathy in the light of new ideology of the modern medicine. Therapy. 2019;(1):182-192. (In Russ.) DOI: 10.18565/therapy.2019.1.182-192
6. Berdysh D.S., Khakui E.S., Beslangurova Z.A., Pustovet D.A. Use of pectin in medical practice. Review article. International Research Journal. 2025;4(154):1-8. (in Russ.) DOI: 10.60797/IRJ.2025.154.76.
7. Volkov A.V., Ruzhentsova T.A., Meshkov I.G. Anti-Inflammatory Effect of a Pectin-Based Drug: Experimental Data. Effektivnaya Farmakoterapiya. 2024;20(50):6–11 (In Russ.) DOI: 10.33978/2307-3586-2024-20-50-6-11
8. Pfeifer L, Classen B. The Cell Wall of Seagrasses: Fascinating, Peculiar and a Blank Canvas for Future Research. Front Plant Sci. 2020;11:588754. DOI: 10.3389/fpls.2020.588754
9. Khavkina D.A., Chukhliaev P.V., Ruzhentsova T.A. Approaches to treatment of recurrent eczema in practice of general practitioner (clinical example). Medical alphabet. 2021;(32):26-29. (In Russ.) DOI: 10.33667/2078-5631-2021-32-26-29
10. Beukema M, Faas MM, de Vos P. The effects of different dietary fiber pectin structures on the gastrointestinal immune barrier: impact via gut microbiota and direct effects on immune cells. Exp Mol Med. 2020;52(9):1364-1376. DOI: 10.1038/s12276-020-0449-2
11. Lazareva E.B., Menshikov D.D. Experience with and prospects of pectins in medical practice. Antibiotics and chemotherapy. 1999;44(2):37–40. (In Russ.) eLIBRARY ID: 14950405 EDN: MPEDVT
12. Khasina E.I., Moiseenko L.I. Protective action of amaranth pectin in gastropathy induced nonsteroidal anti-flammatory drugs. Pacific medical journal. 2013,2;18-21. (In Russ.) eLIBRARY ID: 20191594 EDN: QZWEFR
13. Magamedehminova M.M., Korotkih V.M., Osokina M.M., Malkina E.A., Kravcova K.V., Voznyuk K.S., et al. Pectin: properties and benefits for the body. Young scientist. 2021;7(349):41-43(in Russ.) eLIBRARY ID: 44727940 EDN: XMKTMM
14. Pavlovich Е. D., Nesterova N.V. Biologically active substances of holothuria and experience of their use in medicine. Overview. Traditional medicine. 2020; 3(62):40-45(in Russ.) eLIBRARY ID: 44508662 EDN: HPMZBX
15. Chepkasova A.I., Ayushin N.B., Kuznetsov Yu.N. Prospects of use of minor components of golotury in patient and preventive measures. Health. Medical ecology. Science. 2017;5:35–38. (in Russia). DOI: 10.5281/zenodo.1115450
Review
For citations:
Mokshina M.V., Nevzorova V.A., Kondrashova N.M., Moskalenko A.S., Eliseeva E.V., Priseko L.G. Evaluation of the effectiveness of pectin with trepang extract in the complex therapy of NSAID-associated lesions of the upper gastrointestinal tract. South Russian Journal of Therapeutic Practice. 2026;7(1):62-68. (In Russ.) https://doi.org/10.21886/2712-8156-2026-7-1-62-68
JATS XML


















